Accellacare

Accellacare

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Accellacare is a specialized clinical research site organization that enhances patient access and experience in clinical trials. It operates an integrated network of physical research sites and offers decentralized clinical trial (DCT) solutions, including in-home nursing visits, to reduce participant burden. As a strategic asset within the larger CRO (Contract Research Organization) ICON plc, Accellacare provides sponsors with a patient-centric channel for faster enrollment and improved trial execution. The company represents a hybrid model in the evolving clinical trials landscape, blending traditional site-based research with flexible, digital-enabled services.

OncologyRare & Orphan DiseasesMedical Device

Technology Platform

Integrated clinical research service platform combining a network of physical research sites with decentralized clinical trial (DCT) capabilities, including in-home nursing visits and patient-centric recruitment tools.

Opportunities

The accelerating industry shift towards patient-centric and decentralized clinical trial models presents a major growth opportunity.
As a dedicated network within ICON, Accellacare is well-positioned to capture increased demand from sponsors seeking faster enrollment, improved patient retention, and more diverse participant populations through its hybrid site-and-home service offering.

Risk Factors

Key risks include intense competition from other CRO networks and pure-play DCT technology firms, potential operational complexities in scaling in-home services across different regulatory jurisdictions, and strategic dependence on its parent company, ICON plc, for resources and client flow.

Competitive Landscape

Accellacare competes in the clinical trial execution space against other large, integrated CROs (e.g., IQVIA, Parexel, PPD) that have their own site networks, as well as against specialized decentralized clinical trial technology and service providers (e.g., Science 37, Medable). Its differentiation lies in its branded focus on patient experience and its integrated position within ICON's full-service CRO offering.